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Biological Markers in Reproductive
Epidemiology: Prospects and Precautions
by Zena Stein*t* and Maureen Hatcht"
Webegin bydefining"biological markers" forthe purposes ofthepresentreview, distinguishingmarkers
from other types of information, such as subject reports or conventional clinical data. We find the dis-
tinctions to be hazy. Next, from the standpoint of epidemiologists, we set out circumstances in which
exposure markers might be needed, suggesting requirements for useful markers. We give two instances
(lead, PCB), drawn from studies offemale reproduction, where the use of exposure markers is compared
to environmental or anamnestic data. Effect markers are considered in turn. It is argued that their
usefulness (if they are to be more informative than exposure markers) depends on their sensitivity and
specificity in relation to the disease outcome. Also, their timeliness, and the use that can be made ofthe
gain in time, for individuals and populations is discussed.
In this context, we consider markers of events before and around fertilization; more specifically, we
consider those events that precede the clinical marker of the first missed period. In returning to the
potential usesofbiological markers indiscovering orinterpretingfemalereproductivedisordersthatmight
be owed to environmental causes, we compare markers of the pre- and peri-implantation phases with
markers of the postimplantation phase, drawing on experience with studies of chromosome anomaly in
spontaneous abortion. Finally, we suggest other sensitive reproductive processes for which biological
markers might usefully be developed.
Introduction
Epidemiology, in recent years, has developed more
and more as a science of methods, a compound of sta-
tistics and logic applied to the solution of health prob-
lems. Two factors have probably contributed to this.
First, today, many exposures that are being studied
produce smallerincreases inriskandless obvioushealth
effects than those examined inthe past, so that increas-
ingly sophisticated manipulation of the data is needed
inordertodemonstratethoseassociationsthat are pres-
ent. As professional training adapts to cope with these
demands, the emphasis on abiological understanding of
disease declines among epidemiologists. Second, and
perhaps as important, is the influential philosophy ex-
pressed by some leading epidemiologists, which chal-
lenges ". . . the common perception that understanding
of mechanism is more useful than knowledge of asso-
ciations," on the grounds that "prevention through con-
trolofexposureis oftenfeasible intheabsence ofknowl-
edge of cellular processes" (1).
Otherepidemiologists haveattempted to struggle out
of the shackles of this philosophy, arguing that when-
ever a researcher has useful clues to the likely mode of
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action, he or she has a decided advantage in designing
research to test and quantify associations. As a result
of a stronger design, cause-effect connections may be
detectedthatmightotherwisebeelusive (2). Thethrust
ofthe discussion that follows is analysis ofthe circum-
stances in which biological markers, by bringing us
closer to mechanism, may strengthen epidemiological
strategies. These are the "prospects" referred to in our
title. The "precautions" in the title reflect experience
with an epidemiologic study of aneuploidy involving
analysis of human abortus material (see below). In a
final section, we consider how an epidemiologist might
select biomarkers for exploration, keeping an eye not
only on what it is possible to measure in specific areas
of reproductive function, but also on which outcomes
appear likely to show effects of environmental expo-
sures.
What Are Biological Markers?
Webeginwith definitions since itis alreadyclearthat
in the case of "biological markers," as with "molecular
epidemiology" and even with "genetics," we are at a
Mad Hatter's tea party. Since terms will confound our
discussions unless we apply them in the same way, we
have listed in Table 1 some uses ofterms for which we
need general agreement. The first categoryexcluded as
a biological marker is measures ofthe environment. It
also seems reasonable to exclude subject reports (al-
though these may be subtle and specialized, e.g., anSTEIN AND HATCH
Table 1. Definitions of biological markers.
Biological markers are not Biological markers are
Environmental measures in
air, soil, water, food
Subject reports
Physical, anthropometric, and
mental examination
Material measures obtained
from the bodies or
excretions ofindividuals
Potentially usable to detect:
environmental exposures,
effects of exposures
Do biological markers include representations ofphysiological
activity or function? e.g., EEG, ECG, ultrasound, NMR, blood
pressure, pulse rate
Table 2. Uses of exposure markers in epidemiology.
When fact of exposure known, but quality ofindex or source
questionable (details not known, biased recall, memory failure,
deliberate misinformation)
To validate other information sources
When environmental data are poor approximations of individual
dose (uptake, pharmacokinetics)
To document exposure to target tissue
To quantify the biological load from an exposure
Table 3. Maternal blood lead levels by residence and husband's
occupation, province of Kossovo, Yugoslavia.a
Blood lead level, iLg/dL
Site Mean Range
Mitrovica
Husbands in lead industry
Battery, n = 28 21.6 5.2-41.3
Refinery, n = 8 17.2 11.8-25.5
Smelter, n = 16 16.6 6.9-27.3
Other, n = 79 17.4 3.4-39.7
Husbands not in lead industry,
n=324 17.1 3.1-56.7
Pristina
All women tested, n = 648 5.4 1.3-23.0
aSource: J. Graziano et al., personal communication.
I.Q. assessment is based on questions and responses).
Physical and anthropometric measures may be routine
or highly specialized, traditional or modern-what ex-
cludes them from being "biological markers"? In our
categorization scheme, markers include everything the
examiner could not hear or see or feel or measure at a
routine clinical visit. On the other hand, urinalysis and
hemoglobin estimates, widely accepted as biological
markers, are simple extensions of the clinician's pur-
view, and what do we do with the noninvasive repre-
sentations ofphysiologic activity that we have left un-
determined at the bottom of Table 1? Why should an
imaging evaluation of function be differentiated from
blood or tissue evaluation? For the present, we have
excluded only the everyday bedside measures ofpulse
and blood pressure and included the remaining param-
eters as biological markers. There is no definitive ra-
tionale for these inclusions and exclusions: they are
based on convenience and current thinking and are sub-
ject to change. Nonetheless, agreement is needed on
these usages.
We turn next to a consideration ofexposure markers
on the one hand, and of effect markers on the other.
The distinction between the two seems important, at
least in theory, and we have tried to explore the dis-
tinctionthroughexamplesfromthefield ofreproduction
(Fig. 1). The differences may become more evident if
we take each concept in turn. We begin with exposure
markers (that is, biological measurements of internal
dose or body burden) and the circumstances under
whichtheyservetheneedsofepidemiologists (seeTable
2).
The first set ofcircumstances in the table (relatingto
insufficient details of exposure) is commonly encoun-
tered in epidemiology. It should be remembered, how-
ever, that while an exposure marker might be useful in
this respect, it may not be necessary: careful question-
ingcanoftenbeveryinformative ontherequisitedetail.
Similarly, althoughrecallbias is an ever-present source
ofanxiety to the epidemiologist, study design will often
handle the problem satisfactorily. Memory failures do
occur and increase with lapse oftime, but many biolog-
ical markers fade with time as well. Deliberate misin-
formation confuses the investigator; however, those
who misinform may also be refusers in a testing pro-
gram that requires informed consent. The precautions
maybe summarizedbywarningthatoneneedstoweigh
the potential gains carefully before eschewing conven-
tional methods in favor ofbiological measures.
The second application cited for exposure markers,
the need to validate other sources, is a methodological
use that is certainly valuable to the epidemiologist, es-
pecially one who, for practical reasons, must rely on
exposure histories orrecords in the study population as
a whole but could use exposure markers on a small,
representative subsample.
The next three uses of exposure markers in epide-
miology (the last three entries in Table 2) are of a dif-
ferentorder, fortheymoveustoward anunderstanding
of individual exposures that we could not otherwise in
alllikelihoodreach, evenfromhonest, precise, and care-
fullyrecalled reports. Butwhat evidence dowe actually
have that these three 'biological' uses add strength to
the arm ofthe researcher? We illustrate again both the
prospects and the precautions.
Table 3 provides data on lead exposure to pregnant
women in the province of Kossovo, Yugoslavia, on the
Albanianborder(Graziano, personalcommunication). A
lead smelter has polluted the area around the town of
Mitrovica, affecting not only the workers in the plant
but also the resident population. In Pristina, 40 km
away, many aspects of life are similar, but there is no
pollution by lead. In an investigation headed byJoseph
Graziano, we have been studying the effects of intra-
uterine exposure on the offspring and for this purpose
have measured blood lead levels ofMitrovica and Pris-
tina women when they come for prenatal care, usually
in midpregnancy. The study includes a series of ques-
tions relating to individual exposure, the most useful of
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Exposure - Effect .> Disease/
Marker Marker Disorder
Mariluana. THC in > plasma LH; >infertility
blood salivary
progesterone
Cigarettes > cotinine DNA adducts lowered
in saliva, in birthweight
amniotic fluid fetal tissue
FIGURE 1. Two hypothetical examples of environmental exposure and female reproductive toxicity, showing possible biological markers of
exposure and effect.
whichareplaceofresidence(MitrovicaorPristina), and,
if Mitrovica, was the husband employed at the lead
plant, and, ifyes, whatwasthenatureofhisworkthere.
(The women seldom worked in the plant.)
Table 3 compares the means and ranges ofblood lead
levels for women categorized on the basis of the epi-
demiologic design and the interview data; the table il-
lustrates the added specificity that is gained in this in-
stance from the use ofan exposure markeras compared
with an exposure gradient constructed from detailed
reports. As the data show, while mean blood lead levels
forwomeninMitrovica, thepollutedtown, arethreefold
higherthan forPristinawomen, there seems to be little
additional contribution from the husband's work expo-
sure; in fact, the highest recorded blood level is for a
woman whose husband is not employed in the lead in-
dustry. The other notable feature of the data is the
substantial range in blood levels within exposure cat-
egories, indicating that individual variation in absorbed
dose is appreciable.
It remains to be seen, as follow-up continues, how
useful the biological exposure marker is in identifying
adverse effects, butthe maternalblood lead hasalready
provenits worth as anindex oftransplacental exposure.
Mothers' serum leads, measured midwaythrough preg-
nancy and at term, are very highly correlated with um-
bilical cord blood, so we know the infant's blood reflects
the mother's lead burden during her pregnancy, even
though the mother's level may have been higher or
lower at other times; blood level responds within a few
weeks to exposure changes.
We use another example to embody the precautions.
Table 4 draws on a very thorough study into the effects
on offspring ofa mother's ordinary dietary ingestion of
PCBs (3). Histories of fish consumption (frequency,
type, and timing in relation to pregnancy) were taken
from LakeWisconsin women atthetime ofdelivery and
scored by the investigators in terms of known PCB
content of the species of fish at the time it was eaten.
The table compares outcomes among the offspring ac-
cording to mother's reported total fish consumption, on
theonehand, andPCBlevelintheumbilicalcordserum,
on the other. Both measures work well, but the edge
Table 4. Birth size and gestational age by cumulative
contaminated fish consumption and cord PCB level.'
Fish consumptionb Cord serum PCB levelc
No fish Fish < 3 ng/mL , 3 ng/mL
Parameter (n = 71) (n = 242) (n = 166) (n = 75)
Birth weight, g 3660 3470* 3570 3410*
Head circum-
ference,cm 35.5 35.0* 35.3 34.6*
Gestational
age, weeks 39.9 39.2* 39.4 39.5
Maturity score 20.0 18.5* 20.0 19.0
aSource: Fein et al. (3).
bAdjusted for prepregnancy weight, type ofdelivery, alcohol, caf-
feine, cold remedies.
cAdjusted forinfant sex, type ofdelivery, maternal age, and preg-
nancy weight gain.
*Significantly different from control value, p <0.05.
is with the reported data, and this we explain on the
basis of a finding in the study that it was the mother's
consumption before, as well as during pregnancy (that
is, the cumulative dose) that precipitated these out-
comes; this was a distinction that could not be derived
from the biological marker measured only once, in cord
blood. We show these data to admonish against a mind-
less preference for technical measures.
Tosumup, forourpurposesausefulexposuremarker
should be superior to a report. It must accurately dif-
ferentiate exposed from unexposed individuals and
should, in general, be noninvasive, acceptable, and ap-
plicable on a large scale. Ideally, a marker would pro-
vide a memory ofcumulative exposure interpretable as
time, dose, and duration.
Weturnnexttoeffectmarkers, whichforthemoment
we define as any biologically measurable response to
exposure. It is here, perhaps, that the prospects, and
the uncertainties, as well, loom larger. If epidemiolo-
gists prefer to work one level removed from these un-
certainties, then they should leave the matter ofeffect
markers alone. But, if they hold that epidemiology is
most effectively used as part of an iterative process to
narrow and refine the research questions in collabora-
tion with laboratory and clinical scientists, then they
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will try to identify how each group may complement
andreinforcetheotherinanoverallprogramofresearch
(2).
We set out once again the desiderata for epidemiol-
ogists, in this case for useful effect markers (Table 5).
The first requirement, that information on exposure is
added to anamnestic data, is the most limited. Ifthis is
all an effect marker does, then it is actually functioning
likeanexposure marker; manyofthebiologicalmarkers
in present use (e.g., SCEs, DNA adducts) are of this
type. Among the other desirable attributes listed in
Table5, noninvasiveness isagainagreatadvantage (but
not an absolute). The effect mustbetimely, inthe sense
that it is detectable before the disease supervenes, and
it would naturally be highly desirable ifwith timeliness
go prospects for effective interventions, either for the
individualorforthecommunityatrisk. Stabilityisquite
important. In practice, if a marker does not endure in
the individual over some appreciable period oftime, it
will be less useful than if it does persist, at least until
after the exposure is no longer measurable. The re-
quirement that the marker be sensitive to the environ-
ment is ofcourse crucial in the present context, and we
will have more to say about this shortly.
For nowwe turn to the issue ofprediction. Whether,
and how well, a marker predicts disorder in exposed
individuals is ameasurable characteristic, and itis here
that we see room for the inventive epidemiologist to
play a part. In Figure 2, we have modelled some ofthe
possiblerelationsamongamarkerofexposure, aneffect
marker, and the disease or disorder of concern. First,
ifexposure and effect markers correspond very closely
indeed, there is no benefit in distinguishing one from
the other. At the other extreme, ifeffect markers and
signs/symptoms ofthe disease correspond very closely,
then the virtue of using the effect marker resides en-
tirely in its timeliness and the use that can be made of
the time. An effect marker that correlates very closely
with the disease would not likelyimprove the chance of
detecting cause-effect relationships, although it may
addknowledge ofprocess orofprecursors. If, however,
the effect marker does not correlate closely with the
exposure marker and is prognostic of the disease but
the correspondence with disease is not absolute, then
the gap between exposure, effect, and disease may be
fruitfully explored in the hope ofidentifying individual
susceptibility factors or otherprecipitating circumstan-
ces.
AIDS presents us with aparadigm ofthese relations.
Regarding the presence ofthe virus in the blood as an
exposure marker, what use can be made of the time
Table 5. Requirements for useful effect markers.
Adds infonnation to anamnestic data about exposure
Noninvasive
Timely (early)
Points to effective intervention for exposed individuals or groups
Stable
Sensitive to environmental exposures
Predicts disorder in exposed individuals
gained by knowledge ofinfection before the disease be-
comes manifest? If only a proportion of those infected
are destined togetthedisease, whataretheriskfactors
forthedisease amongtheinfected? Inthistype ofprob-
lem, modern, sophisticated epidemiologic models and
methods are available.
Areas of Reproductive Function
Ripe for Development of Biological
Markers
Wereturnnowtoaconsiderationofbiologicprocesses
that may be sensitive to environmental exposures. In
Figure3, we denote conception, pre-, peri-, andpostim-
plantation ofthezygoteinthehuman, markingthenum-
ber of days from ovulation. On day 15 postovulation, a
woman who has a regular menstrual cycle might first
suspect a pregnancy. Validated biological markers that
fertilization has occurred and that the conceptus has
survived at least to implantation have now been pro-
vided [for a fuller discussion, see the paper by Canfield
and colleagues, (4)]. These sensitive new assays permit
observations that previously could begin only 1 or 2
weeks later. Thus, the biologic markers ofimplantation
[and perhaps, soon, of conception; see Faulk (5)] open
up arealmforstudyvirtuallyunexplored since the clas-
sic investigations of Hertig (6).
In a similar spirit of excitement and discovery, we
began more than a decade ago to explore the distribu-
tion and determinants of the aberrant chromosomal
forms in clinically recognized miscarriage (7). Along
with epidemiologic data on parental characteristics and
exposures, the products of conception were collected
and karyotyped. We draw on that experience now to
offer some precautions.
After a decade of research into human aneuploidy,
we have come to the view that human chromosomal
aberrations, while certainly numerous, varied, and fas-
cinating in their own right, respond rather little, if at
all, to the range of environmental influences which we
have been able to study (e.g., cigarettes, alcohol, sper-
micides, occupation) (8). It has been possible to docu-
mentsomeslightadverse effects onchromosomallynor-
malconceptuses [forinstance, cigarette smoking(9) and
maternal fever (10)], but the thousands of karyotyped
miscarriages studied have revealed little evidence that
the anomalies are sensitive to the environment. The
associations that others have reported based on unkar-
yotyped series ofmiscarriages are also probably due to
a raised risk of chromosomally normal spontaneous
abortions since these comprise the majority of miscar-
riages, anditwouldtakealargeincreaseinchromosome
anomaly to raise the overall rate of miscarriage (11).
Additional support for this view of the relative sensi-
tivity of normal and abnormal conceptions comes from
the observation that specific chromosome anomalies
vary very little across studies in different populations,
whereas chromosomally normal abortions do vary in
frequency. The data from our series in New York and
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Exposure Marker
Effect Marker
* correlates closely with exposure status,
weakly (or not at all) with disease.
Disease/Disorder
Exposure Marker * * * 0**0 * * ** * Effect Marker * * * * * * * * Disease/Disorder
* present in only some of the exposed;
* strongly prognostic, in ways not explained
by knowledge of exposure (cofactors,
susceptibility);
* timely (i.e., lead time for prevention;
intervention still possible.
FIGURE 2. Schematic representation of two possible relationships among exposure markers, effect markers, and reproductive disease or
disorders. In the first, the effect marker, while a measure of response, is linked closely to exposure but very weakly to disease. In the
second, the effect marker is directly in the pathway between exposure and disease.
No validated
< lndictors of->
pregnancy (EPF?)
Zygote
day I
C - bCC
(IRMA etc.)
pert-fertilization pre-implantation pert-implantation post-implantation
FIGURE 3. Sources of material and biological markers relating to events from the time offertilization up to the first missed period.
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FIGURE 4. Gestational age distributions of(A) euploid; (B) trisomic; (C) monsomic X; and (D) triploid spontaneous abortions from fourseries.
The series are represented in the graphs as follows: Hiroshima (A); Hawaii (U); New York (O); London (X). Source: Kline and Stein (8).
Figure continued on next page.
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for series in London, Honolulu, and Hiroshima are
shown in Figure 4.
How do these inferences about recognized miscar-
riage bear on observations of very early losses (peri-
and early postimplantation losses that would seldom
enteraseriesofhospitalizedmiscarriages)? Itisentirely
too soon to say with any certainty, but we may spec-
ulate, first, that the majority of very early losses are
chromosomal anomalies, and second, if this is so, that
environmental influences on this distribution will prob-
ably not be marked.
There are several lines ofevidence in support ofthe
first point (that the majority of very early losses are
chromosomally abnormal). First is the observation that
in recognized miscarriage (in spite of some irregulari-
ties, possibly artifactual), the prevalence of chromo-
some anomaly generally increases as gestation time of
the abortus decreases (12). Second, there is the theo-
retical argument that many chromosome anomalies
which are believed to occur are presently unaccounted
for and so are presumed to be lost very early on. For
example, monosomy might be as frequent as trisomy
(thatis, therewouldbeamissingchromosome forevery
supernumerary one), butmonosomiesareobservedonly
halfas often trisomies in recognized pregnancies; ergo,
the missing monosomies could have been lost in the
preclinical period. There is evidence in the mouse to
suggest that this is so (13). In addition, there are tri-
somies of specific chromosomes that are underrepre-
sented in recognized pregnancies and so are presump-
tive early losses (14). Chromosomal studies would be
requiredtoestablish thiswithcertainty, butthesestud-
ies are at present technically infeasible.
On the second point (that the likelihood of environ-
mental influences will be less, the greater the concen-
tration ofchromosomal anomalies) there are indications
that the experience in very early loss will parallel that
ofclinical miscarriage. For example, a review by Baird
and Wilcox ofthe toxicologic literature (15) found that
preimplantation loss was induced by much the same
exposures as causedpostimplantation loss. It seems un-
likely that inthe human a new and distinct setofcauses
ofenvironmental origin willspecifically, and only, cause
peri-implantation loss. Ofcourse, this can only be con-
firmed empirically. Moreover, it will be interesting and
important to establish the natural history ofvery early
loss, even apart from the question of environmental
influences.
By contrast, ovarian function is an aspect of female
reproductionthatdoesapparentlyreflectenvironmental
factors. There are several epidemiological pointers to
suggest this is so. We know, for instance, that there
are environmental effects on menarche related to nu-
tritional factors (16). Extreme physical exertion (17),
starvation (18), andpsychic strain (19)havebeenshown
to alterovulation inwomenwith established cycles, and
there aredatasuggestingthatexposuretosolvents(20),
metals (21), estrogens (22), and chemotherapeutic
agents (23) induces menstrual disorders.
Contemporaneous cigarette smoking is associated
withanearliermenopause(24). Isthisfindingconnected
with the observation that contemporaneous cigarette
smokingdelaysconceptionincouplesattemptingapreg-
nancy? We do not know if cigarette smoking impedes
ovulation or induces very early (preclinical) loss. How-
ever, a recent study documents in biological detail the
antiestrogenic effect of women's smoking (25), and a
similar pathway for estrogen metabolism has been
shown for malnutrition and weight loss (26,27), factors
which do disturb ovulation.
We might be able to establish the underlying cause
of smoking-induced conception delay and perhaps dis-
cern new associations if the epidemiology of ovulatory
failure could be studied using biological markers. For
several reasons (e.g., applicability to nonconceptive
women) ovulation would be easier to study in popula-
tions than early pregnancy ifan acceptable noninvasive
marker of ovulation were available. While irregular
menses is a usual accompaniment of ovulatory failure,
this is not always the case, and it would be a great
advantage to have amarker. Measures ofprogesterone
in urine (28) and saliva (29) have been bruited. A heat-
sensitive device, more sophisticated and acceptable
than a rectal thermometer, would be a useful tool.
Anovular cycles indicate ahormonal cause, a somatic
change, ratherthan onethatisgeneticorchromosomal,
within the genome. Here we venture a generalization:
there is more evidence that the environment induces
damage to the somatic cells-in the woman, mediated
through the endocrinal system, and in the embryo,
through the placenta-thanthat the environment dam-
agesthegenome ofsubsequentgenerations. This seems
to be one of the lessons from experimental toxicology.
Then, for delayed conception, as with smokers, we
should first suspect irregular ovulation; ifthere is very
early loss (of presumably chromosomally normal con-
ceptuses), we might suspect hormonal inadequacy.
However, hormonalinadequacywill be difficult to dem-
onstrate without large numbers if, as we predict, most
very early losses are chromosomally abnormal.
We know that observable chromosomal anomalies (at
miscarriage and at term) seem related to maternal age
(30) in a seemingly constant fashion and not, insofar as
they have been studied, related to any of the usual
environmental influences. These observations fit with
laboratory findings: oocytes can be induced to atrese,
anomalies ofdevelopment can be induced during preg-
nancy, but prepregnancy exposure ofthe female cannot
easily be demonstrated to result in miscarriage or ge-
netic birth defects. In the female (mouse as well as
human), the stored eggs seem to be exceptionally well
insulated, even against the myriads of new products
being synthesized daily and released into our environ-
ment.
In summary, we knowthrough epidemiologythatthe
following reproductive functions are responsive to en-
vironmental factors: the onset ofthe menarche; ovula-
tion, for those with established cycles; the menopause;
and the development ofthe chromosomally normal em-
bryo and fetus. In terms of uncovering new environ-
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mental hazards to female reproduction, the epidemiol-
ogist would be well served by the development of
biological markers for these events, especially ifmark-
ers can be designed to incorporate the desirable attri-
butes enumerated earlier.
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